SBIR/STTR Research Award

Statistical Methods for Evaluating Longitudinal Biomarkers in Treatment Selection and Diagnostic Tests

Award identifier 453c7b6ac6e701504797411e27cc77b2a68957f602102ce83273ac33bc220c1fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$254,404

Program and phase

SBIR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Data Numerica Institute, Inc.
Proposal award date
2019-09-04
Contract end date
2020-06-03
UEI
Not reported
Solicitation number
PA18-574
Topic code
400

Research abstract

In this researchwe will study two related statistical topics aiming at evaluating longitudinal biomarkers that have impacts on clinical outcome and individualized medical decisionThe results of this study will be applicable to classifying patientsresponse rates based on marker evaluationpredicting disease onsetand selecting treatment protocol that would benefit individual patientsIn treating colon cancerthe patientssurvival rates might be associated with the interaction of surgery and biomarkerse gc myc gene expression levelsIn HIV studiesHIVRNA and CDlevels may result in different outcomes for various treatment groupsSuch biomarkers could be indicators predictors of which patient groups may benefit more from specific treatment optionsMarker evaluation methods and tools are critical in finding the optimal treatment protocol for patientsWe will develop a comprehensive and user friendly environment for analyzing marker dataand the first goal focuses on marker evaluation in treatment selectionTypicallya selection criterion is based on a threshold of a markerAn innovative approach is to evaluate a selection policy by the Selection ImpactSIscore based on the treatment assignment proportion of a given thresholdBy plotting such proportions and the SI score of a given thresholdone can easily find the optimal threshold of biomarker as well as the best marker in marker comparisonOur second goal focuses on the classification capability of markers in selecting diagnostic tests based on marker valuesReceiver Operating CharacteristicsROCcurve is the traditional method in evaluating images in radiological studiesThe challenges are that the level of biomarker may vary over time and the clinical outcome might be a time toevent with censored valuesTypicallythe conventional image diagnostic tests focus on binary outcome with fixed marker values at the baselinee gpositive or negative results in tumor evaluationWe will emphasize more on ROC curve for longitudinal markers and survival outcomeAt the endwe will develop various methods for SI and ROC curves and integrate them into a user friendly statistical softwareWith such toolswe will promote the applications of time varying markers and predictors in personalized treatment decision This project will provide statistical software with advanced methods useful for marker selectionevaluationand personalized treatmentStatistical methodsgraphicscomputational environment and case studies will be developed

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.